Please Wait...

Cardiac Safety

World-renowned scientific expertise, regulatory leadership and integrated technology for high quality centralized cardiac safety trials.

Cardiovascular Safety Services from Bioclinica

With over 25 years of experience in Cardiac Safety monitoring services, Bioclinica is a recognized global leader in providing comprehensive services with unrivalled scientific and technical leadership. Bioclinica's medical and scientific team, consisting of board-certified cardiologists and active members of the Cardiac Safety Research Consortium, has strong experience in successfully designing and supporting studies that require cardiac safety monitoring. Our focus goes beyond the single study and across the entire cardiac safety profile of the study compound from Phase I–IV. With experience working alongside the ICH, FDA, EMA, PMDA, and SFDA in the development of regulatory and industry guidelines, Bioclinica is the smart choice to support the design and conduct of cardiac safety studies around the globe.

ECG MEASUREMENTS

Manual and automated ECG analysis and Digital Holter analysis.
LEARN MORE

THOROUGH QT STUDIES

Innovative and conventional TQT study design and support.
LEARN MORE

BLOOD PRESSURE

Ambulatory and Automated Blood Pressure and Pulse Wave Analysis.
LEARN MORE

CARDIOVASCULAR IMAGING

Cardiac safety endpoints using a range of imaging modalities.
LEARN MORE

PROTOCOL DESIGN AND EXPERT REPORTING

Study design and Consultative Services.
LEARN MORE

WEBHEART PLATFORM

Robust, validated trial management tool.
LEARN MORE

SCIENTIFIC & REGULATORY EXPERTISE

30+ years of proven strategic expertise.
LEARN MORE

COLLATERAL

Learn more & eBrochures.
LEARN MORE

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Bioclinica is organized into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging & Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Molecular Marker Laboratory. Our eHealth segment comprises eClinical Solutions, Randomization & Trial Supply Management, Safety & Regulatory Solutions, and Financial Lifecycle Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

"Mud run" 1 obstacle in vaccine trials w elderly. Here R 5 more & how to conquer by Dr. Craig Curtis… https://t.co/vIk4B2Howd
bioclinica (5 hours ago)
What's new in tech for ICH E6 R2 reqs for quality and #RBM? https://t.co/xsmNm8d35o #Pharma
bioclinica (8 hours ago)
Vaccine clinical trials: Boost senior participation following simple advice from Dr. Craig Curtis… https://t.co/OuTKyu0DPT
bioclinica (9 hours ago)
RT @ElisendaGendra: Decision on #EMA Relocation Set for November, Council Agrees on Bidding Procedure via @RAPSorg https://t.co/a42Eszg81o…
bioclinica (Yesterday)
@Xtalks Looking forward to tomorrow's webinar on site payments!
bioclinica (Yesterday)
Conducting Lymphoma ClinicalTrials? Lugano 2014 criteria for assessing FDG-PET/CT. An operational appch https://t.co/x5bdpI8jUI
bioclinica (Yesterday)

Latest Blogs: